Literature DB >> 29800920

TGF-β2 induces proliferation and inhibits apoptosis of human Tenon capsule fibroblast by miR-26 and its targeting of CTGF.

Huijing Bao1, Kai Jiang2, Kai Meng3, Wenjing Liu4, Ping Liu4, Yunhong Du4, Dabo Wang5.   

Abstract

AIM: The aim of this study was to research the effect of TGF-β2 on human enon capsule fibroblasts proliferation and apoptosis and its potential mechanism.
METHODS: Human eyeball fascia tissues (n = 45) were derived from ocular fascia tissues of patients who were underwent glaucoma filtration surgery, and Tenon capsule fibroblasts were obtained from these tissues. Liposome-mediated transfection, CCK8 assay, Hoechst33258 staining, qRT-PCR detection, western blot, and luciferase reporter assay were performed.
RESULTS: TGF-β2 promoted proliferation and inhibited apoptosis of human Tenon capsule fibroblasts in a dose-dependent manner. TGF-β2 induced down-regulation of miR-26 and up-regulation of CTGF in a dose-dependent manner. CTGF was the target gene of miR-26 and miR-26 had a negative regulatory effect on CTGF expression. miR-26 up-regulation could significantly decrease proliferation and increase apoptosis of human Tenon capsule fibroblasts after induced by TGF-β2 (P < 0.05). Down-regulation of CTGF could markly decrease proliferation and increase apoptosis of human Tenon capsule fibroblasts after induced by TGF-β2 (P < 0.05).
CONCLUSION: miR-26 could inhibit proliferation and promote apoptosis of human Tenon capsule fibroblasts after they were induced by TGF-β2 through suppressing CTGF expression.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; CTGF; Proliferation; Tenon capsule fibroblasts; miR-26

Mesh:

Substances:

Year:  2018        PMID: 29800920     DOI: 10.1016/j.biopha.2018.05.059

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

2.  miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease.

Authors:  Bin Wang; Aiqing Zhang; Haidong Wang; Janet D Klein; Lin Tan; Ze-Mu Wang; Jie Du; Nawazish Naqvi; Bi-Cheng Liu; Xiaonan H Wang
Journal:  Theranostics       Date:  2019-03-07       Impact factor: 11.556

3.  miR-125 regulates PI3K/Akt/mTOR signaling pathway in rheumatoid arthritis rats via PARP2.

Authors:  Kai Liu; Yingang Zhang; Liang Liu; Qiling Yuan
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

4.  Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer.

Authors:  Xiaobo He; Xiao Cheng; Jianfeng Ding; Maoming Xiong; Bo Chen; Guodong Cao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 5.  Emerging Evidence of Noncoding RNAs in Bleb Scarring after Glaucoma Filtration Surgery.

Authors:  Sabrina Yu; Alex L C Tam; Robert Campbell; Neil Renwick
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.